Screener
Ginkgo Bioworks DNA Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's invested capital?
- Ginkgo Bioworks (DNA) reported invested capital of $652.38M in Q2 2026.
- How has Ginkgo Bioworks's invested capital changed year-over-year?
- Ginkgo Bioworks's invested capital decreased by 17.5% year-over-year, from $790.43M to $652.38M.
- What is the long-term trend for Ginkgo Bioworks's invested capital?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's invested capital has grown at a 51.6% compound annual growth rate (CAGR), from $92.02M to $736.1M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Ginkgo Bioworks's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude